No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SXTP 60 Degrees Pharmaceuticals
- 1.260
- -0.150-10.64%
Close Dec 20 16:00 ET
- 1.300
- +0.040+3.17%
Post 20:01 ET
2.89MMarket Cap-0.39P/E (TTM)
1.470High1.260Low147.32KVolume1.380Open1.410Pre Close198.66KTurnover7.65%Turnover RatioLossP/E (Static)2.30MShares18.36052wk High-0.82P/B2.43MFloat Cap0.70252wk Low--Dividend TTM1.92MShs Float103.800Historical High--Div YieldTTM14.89%Amplitude0.701Historical Low1.348Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | 60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
60 Degrees Pharmaceuticals Chairman Geoffrey Dow Reported Purchase Of 73,951 Shares @ Avg Price Of $1.21/Share In Form 4 Filing On Monday
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
Heat List
US
Overall
Symbol
Price
% Chg
No Data